BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/12/2020 4:09:15 AM | Browse: 551 | Download: 585
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 57419
Country/Territory China
Received
2020-06-09 06:46
Peer-Review Started
2020-06-09 06:47
To Make the First Decision
Return for Revision
2020-07-04 21:40
Revised
2020-07-15 08:38
Second Decision
2020-09-17 13:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-09-18 20:23
Articles in Press
2020-09-18 20:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
2020-10-07 03:26
Typeset the Manuscript
2020-11-09 15:19
Publish the Manuscript Online
2020-11-12 03:59
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Meta-Analysis
Article Title Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Li Yang, Xian-Zhe Dong, Xiao-Xuan Xing, Xiao-Hui Cui, Lin Li and Lan Zhang
Funding Agency and Grant Number
Funding Agency Grant Number
Beijing Hospitals Authority Ascent Plan DFL20190803
Capital Science and Technology Leading Talent Training Project Z191100006119017
National Nature and Science Foundation of China 81773778
China Postdoctoral Science Foundation 2019M650775
Corresponding Author Lan Zhang, PhD, Professor, Department of Pharmacy, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing Engineering Research Center for Nervous System Drugs, Beijing Institute for Brain Disorders, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, No. 45 Changchun Street, Xicheng District, Beijing 100053, China. lanizhg@126.com
Key Words Gastric cancer; Gastroesophageal junction cancer; Anti-PD-1/anti-PD-L1 antibody therapy; Meta-analysis; Systematic review;
Core Tip Anti-PD-1/anti-PD-L1 antibody therapy, such as nivolumab and pembrolizumab, which has been approved by the FDA for marketing, enhances the body′s cellular immune response to anti-tumor effects by regulating T cell function. At present, it has become the first-line treatment for extensive stage small cell lung cancer and other cancers. In recent years, some clinical trials have also shown that anti-PD-1/anti-PD-L1 antibody therapy has a reliable effect in advanced gastric cancer or gastroesophageal junction cancer (GC/GEJC) patients, but there is still controversy. The main purpose of this review is to comprehensively evaluate the efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced GC/GEJC patients.
Publish Date 2020-11-12 03:59
Citation Yang L, Dong XZ, Xing XX, Cui XH, Li L, Zhang L. Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis. World J Gastrointest Oncol 2020; 12(11): 1346-1363
URL https://www.wjgnet.com/1948-5204/full/v12/i11/1346.htm
DOI https://dx.doi.org/10.4251/wjgo.v12.i11.1346
Full Article (PDF) WJGO-12-1346.pdf
Full Article (Word) WJGO-12-1346.docx
PRISMA 2009 Checklist 57419-PRISMA-2009-Checklist-revision.doc
Manuscript File 57419-Review_WangTQ.docx
Answering Reviewers 57419-Answering reviewers.pdf
Audio Core Tip 57419-Audio core tip.mp3
Biostatistics Review Certificate 57419-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 57419-Conflict-of-interest statement.pdf
Copyright License Agreement 57419-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 57419-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 57419-Language certificate.pdf
Peer-review Report 57419-Peer-review(s).pdf
Scientific Misconduct Check 57419-Bing-Yan JP-1.png
Scientific Misconduct Check 57419-Scientific misconduct check.pdf
Scientific Editor Work List 57419-Scientific editor work list.pdf